Literature DB >> 24232126

Dapsone and body mass index in subjects with multibacillary leprosy.

Fernanda M L Moura1, Rosa M Dias, Eliete C Araujo, Laélia M B F Brasil, Michelle V D Ferreira, Jose L F Vieira.   

Abstract

BACKGROUND: The physiological changes in obese subjects can modify the pharmacokinetic profiles of drugs influencing the therapeutic efficacy.
METHODS: In this study, the authors compare plasma dapsone trough levels of multibacillary leprosy subjects stratified by body mass index (BMI) to evaluate if obesity plays a significant role on drug levels. The relationship between drug levels and BMI was also determined. Dapsone was measured by high-performance liquid chromatography and BMI based on World Health Organization criteria.
RESULTS: At steady state, the median plasma dapsone trough level was significantly lower in obesity class 2 group, when compared with other groups, but they were similar between normal weight and preobesity groups. A weak association between drug levels and BMI was observed.
CONCLUSIONS: Obesity promotes a significant reduction in plasma dapsone trough levels of subjects with multibacillary leprosy with a weak association between drug levels and BMI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24232126     DOI: 10.1097/FTD.0b013e3182a8f0c8

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  5 in total

1.  Correlation between therapy and lipid profile of leprosy patients: is there a higher risk for developing cardiovascular diseases after treatment?

Authors:  Rosalba V G Silva; Rafael S de Araújo; Tinara L S Aarão; Paulo Diovanne da Silva Costa; Jorge R Sousa; Juarez A S Quaresma
Journal:  Infect Dis Poverty       Date:  2017-05-01       Impact factor: 4.520

Review 2.  Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review.

Authors:  Luka Verrest; Thomas P C Dorlo
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

3.  Refractory Methemoglobinemia Secondary to Topical Dapsone With Subsequent Autoimmune Hemolytic Anemia.

Authors:  Catharine Cantrell; Vincent Costers; Chandler C Wilson; Christopher J Dudek; Justin K Arnold
Journal:  Cureus       Date:  2022-09-05

4.  Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations.

Authors:  R G Hall; J G Pasipanodya; M A Swancutt; C Meek; R Leff; T Gumbo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-07-13

5.  Protein profile of leprosy patients with plantar ulcers from the Eastern Amazon region.

Authors:  Marineia Porto de Oliveira; Jorge Rodrigues de Sousa; Rafael Silva de Araujo; Tinara Leila de Sousa Aarão; Juarez Antonio Simões Quaresma
Journal:  Infect Dis Poverty       Date:  2017-09-04       Impact factor: 4.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.